Ravi Samavedam
About Ravi Samavedam
Ravi Samavedam Chief Innovation Officer
Ravi Samavedam serves as the Chief Innovation Officer, leveraging over 20 years of experience in the biochemical engineering field. His role entails driving technological advancements and innovative solutions within the company. With a robust background in multiple aspects of pharmaceutical operations, including technical operations and quality departments, Samavedam plays a crucial role in steering the company's strategic direction.
Ravi Samavedam Biochemical Engineer
Ravi Samavedam is a seasoned biochemical engineer. His expertise encompasses phase-appropriate cGMP implementation, process validation, supplier management, and technology transfer. Samavedam's extensive experience in the pharmaceutical manufacturing sector has equipped him with diverse technical skills essential for his current leadership role.
Ravi Samavedam Azzur Group Experience
Ravi Samavedam joined Azzur Group in 2012 and has held various key positions within the organization. He served as President of Azzur Cleanrooms on Demand, where he led initiatives to enhance operational efficiencies. Prior to this role, he was the General Manager of Azzur Boston, overseeing critical functions in technical operations and compliance. His extensive background in pharmaceutical manufacturing supports his strategic insights and decision-making at Azzur Group.
Ravi Samavedam Industry Expertise
With a focus on biochemical engineering, Ravi Samavedam has developed significant expertise in areas such as cGMP implementation, process validation, supplier management, and technology transfer. His experience spans across technical operations, quality, and validation departments in leading pharmaceutical companies. He is an active member of various industry and peer groups, staying current with industry trends and best practices.
Ravi Samavedam Public Speaking and Industry Involvement
Ravi Samavedam is a frequent speaker at industry events, sharing his insights on current trends and developments in the pharmaceutical sector. He actively engages with industry and peer groups, contributing to the broader community through knowledge sharing and professional collaboration. His involvement in these activities underlines his commitment to driving innovation and excellence within the industry.